Jeffrey Ludwig Jerome's Insider Trades & SAST Disclosures
Jeffrey Ludwig Jerome's most recent trade in Puma Biotechnology Inc was a trade of 66,221 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 7, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Jeffrey Ludwig Jerome.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 66,221 | 66,221 | - | - | Stock Option (Right to Buy) | |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 47,841 | 156,792 (0%) | 0% | 0 | Common Stock | |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.15 per share. | 02 Jan 2025 | 9,437 | 108,951 (0%) | 0% | 3.2 | 29,743 | Common Stock |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 17 Jul 2024 | 2,598 | 118,388 (0%) | 0% | 3.7 | 9,615 | Common Stock |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.27 per share. | 02 Jul 2024 | 6,051 | 120,986 (0%) | 0% | 3.3 | 19,778 | Common Stock |
|
Puma Biotechnology Inc
|
Jerome Ludwig Jeffrey | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 37,466 | 37,466 | - | - | Stock Option (Right to Buy) | |
|
Puma Biotechnology Inc
|
Ludwig Jeffrey Jerome | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 27,067 | 127,037 (0%) | 0% | 0 | Common Stock | |
|
Puma Biotechnology Inc
|
Jeffrey Ludwig Jerome | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 4.49 per share. | 03 Jan 2024 | 12,956 | 99,970 (0%) | 0% | 4.5 | 58,119 | Common Stock |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.31 per share. | 03 Jul 2023 | 12,103 | 112,926 (0%) | 0% | 3.3 | 40,075 | Common Stock |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 93,028 | 93,028 | - | - | Stock Option (Right to Buy) | |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 66,972 | 125,029 (0%) | 0% | 0 | Common Stock | |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 4.18 per share. | 03 Jan 2023 | 6,568 | 58,057 (0%) | 0% | 4.2 | 27,440 | Common Stock |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.63 per share. | 05 Jul 2022 | 5,835 | 64,625 (0%) | 0% | 2.6 | 15,355 | Common Stock |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 55,882 | 55,882 | - | - | Stock Option (Right to Buy) | |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 39,118 | 70,460 (0%) | 0% | 0 | Common Stock | |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.20 per share. | 03 Jan 2022 | 4,727 | 31,342 (0%) | 0% | 3.2 | 15,121 | Common Stock |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 36,069 | 36,069 (0%) | 0% | 0 | COMMON STOCK | |
|
Puma Biotechnology Inc
|
Jeffrey Jerome Ludwig | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2020 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges